Alector (ALEC) Notes Payables (2025 - 2026)
Alector's (ALEC) quarterly Notes Payables came in at $1.5 million in Q1 2026, up 304.37% quarter-over-quarter from $366000.0 in Q4 2025.
Powered by 
Analysis
Alector (ALEC) Notes Payables (2025 - 2026) Analysis & Trends
Alector (ALEC) has reported Notes Payables for 2 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $366000.0, changed N/A from the prior year.
- Notes Payables was $1.5 million for Q1 2026 at Alector, up from $366000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $1.5 million in Q1 2026 and troughed at $366000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |